The information highlighted (if any) are the most recent updates for this brand.
Both CYP3A4 and CYP2D6 are responsible for Abilify Oral Solution metabolism. Agents that induce CYP3A4 (eg, carbamazepine) could cause an increase in Abilify Oral Solution clearance and lower blood levels. Inhibitors of CYP3A4 (eg, ketoconazole) or CYP2D6 (eg, quinidine, fluoxetine or paroxetine) can inhibit Abilify Oral Solution elimination and cause increased blood levels.